description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
AAACGAGCTCTCACCCAAGAATTCGTAGAGAACATGTCACCCAACGACAAAGTCATCATGTTTGTCAGCCAAAAACATATTGCTGATGACTTGTCAAGCGACTTCAATATCCAAGGCATATCTGCAGAATCATTACATGGCAACAGTGAACAGAGTGATCAAGAGCGAGCAGTAGAGGACTTTAAAAGCGGAAACATAAAGATACTGATTACAACTGATATAGTATCCCGAGGTCTTGATCTTAATGATGTCACACATGTATATAATTATGATTTCCCAAGGAATATTGACGTATATGTACACAGAGTAGGGTTGGACGGACAGGAAAGACTGTCAGTTACCCTCATCACTCAGAGAGATTCGAAAATGGCCGGTGAATTGATTAAAATTCTGGACAGAGCAAATCAGAGTGTTCCGG
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... DDX53(168400)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
F Yuan et al.
European review for medical and pharmacological sciences, 25(1), 127-138 (2021-01-29)
Nasopharyngeal carcinoma (NPC) is a common cancer with high incidence in Southern China. Taxol is one of the first-line chemotherapeutic drugs for treating NPC; however, Taxol resistance has become the main difficulty for clinical treatment and the mechanisms remain not
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EHU026021-20UG | 04061828586028 |
| EHU026021-50UG | 04061828351565 |